These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Correlation between serum levels of free light chain and phenotype of plasma cells in bone marrow in primary AL amyloidosis. Shimojima Y; Matsuda M; Gono T; Ishii W; Fushimi T; Hoshii Y; Yamada T; Ikeda S Amyloid; 2005 Mar; 12(1):33-40. PubMed ID: 16076609 [TBL] [Abstract][Full Text] [Related]
24. Systemic Immunoglobulin Light Chain Amyloidosis-Associated Myopathy: Presentation, Diagnostic Pitfalls, and Outcome. Muchtar E; Derudas D; Mauermann M; Liewluck T; Dispenzieri A; Kumar SK; Dingli D; Lacy MQ; Buadi FK; Hayman SR; Kapoor P; Leung N; Chakraborty R; Gonsalves W; Russell S; Lust JA; Lin Y; Go RS; Zeldenrust S; Kyle RA; Rajkumar SV; Gertz MA Mayo Clin Proc; 2016 Oct; 91(10):1354-1361. PubMed ID: 27712634 [TBL] [Abstract][Full Text] [Related]
26. Isolation and biochemical characterization of plasma monoclonal free light chains in amyloidosis and multiple myeloma: a pilot study of intact and truncated forms of light chains and their charge properties. Kaplan B; Ramirez-Alvarado M; Dispenzieri A; Zeldenrust SR; Leung N; Livneh A; Gallo G Clin Chem Lab Med; 2008; 46(3):335-41. PubMed ID: 18254719 [TBL] [Abstract][Full Text] [Related]
27. Serum free light chain analysis in the diagnosis and management of multiple myeloma and related conditions. Graziani MS; Merlini G Expert Rev Mol Diagn; 2014 Jan; 14(1):55-66. PubMed ID: 24308339 [TBL] [Abstract][Full Text] [Related]
29. A novel approach for the purification and proteomic analysis of pathogenic immunoglobulin free light chains from serum. Lavatelli F; Brambilla F; Valentini V; Rognoni P; Casarini S; Di Silvestre D; Perfetti V; Palladini G; Sarais G; Mauri P; Merlini G Biochim Biophys Acta; 2011 Mar; 1814(3):409-19. PubMed ID: 21215335 [TBL] [Abstract][Full Text] [Related]
30. [The prognostic value of baseline serum free light chain in cardiac amyloidosis]. Zhao L; Tian Z; Fang Q Zhonghua Nei Ke Za Zhi; 2016 Mar; 55(3):186-90. PubMed ID: 26926369 [TBL] [Abstract][Full Text] [Related]
31. Immunofixation electrophoresis was highly specific for the diagnosis of renal light-chain amyloidosis. Zhou FD; Zhang LX; Yao Y; Wang SX; Zou WZ; Liu G; Chen M; Zhao MH Am J Med Sci; 2013 Jan; 345(1):18-21. PubMed ID: 22627261 [TBL] [Abstract][Full Text] [Related]
32. Risk factors for venous thromboembolism in immunoglobulin light chain amyloidosis. Bever KM; Masha LI; Sun F; Stern L; Havasi A; Berk JL; Sanchorawala V; Seldin DC; Sloan JM Haematologica; 2016 Jan; 101(1):86-90. PubMed ID: 26452981 [TBL] [Abstract][Full Text] [Related]
33. [Current methods of systemic amyloidosis diagnosis and monitoring of its course]. Rameev VV; Kozlovskaia LV; Malinina EA; Serova AG; Kogarko IN; Kogarko BS; Liubimova NV Ter Arkh; 2011; 83(8):48-54. PubMed ID: 21961333 [TBL] [Abstract][Full Text] [Related]
34. Light-chain (AL) amyloidosis: diagnosis and treatment. Sanchorawala V Clin J Am Soc Nephrol; 2006 Nov; 1(6):1331-41. PubMed ID: 17699366 [TBL] [Abstract][Full Text] [Related]
35. Life-threatening hematuria in a hemodialysis patient with systemic light-chain amyloidosis. Hsiao PJ; Chiang WF; Chao TK; Lin SH Clin Chim Acta; 2015 Dec; 451(Pt B):180-2. PubMed ID: 26434538 [TBL] [Abstract][Full Text] [Related]
36. [Primary amyloidosis and thrombophlebitis as complications of Bence-Jones plasmacytoma (lambda type)]. Baier J; Neumann H; Grossmann R; Ricken D Med Klin (Munich); 1991 Jan; 86(1):53-7. PubMed ID: 1901936 [No Abstract] [Full Text] [Related]
37. Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System. Barros-Gomes S; Williams B; Nhola LF; Grogan M; Maalouf JF; Dispenzieri A; Pellikka PA; Villarraga HR JACC Cardiovasc Imaging; 2017 Apr; 10(4):398-407. PubMed ID: 27639764 [TBL] [Abstract][Full Text] [Related]
38. [Usefulness of a free light chain immunoassay in serum for the diagnosis and the follow-up of monoclonal gammopathy]. Guenet L; Decaux O; Lechartier H; Ropert M; Grosbois B Rev Med Interne; 2007 Oct; 28(10):689-97. PubMed ID: 17566612 [TBL] [Abstract][Full Text] [Related]
39. Trends in Survival and Renal Recovery in Patients with Multiple Myeloma or Light-Chain Amyloidosis on Chronic Dialysis. Decourt A; Gondouin B; Delaroziere JC; Brunet P; Sallée M; Burtey S; Dussol B; Ivanov V; Costello R; Couchoud C; Jourde-Chiche N Clin J Am Soc Nephrol; 2016 Mar; 11(3):431-41. PubMed ID: 26728585 [TBL] [Abstract][Full Text] [Related]